Latest Breaking News On - Morphosys company profile - Page 1 : comparemela.com

MorphoSys (MOR) to Release Quarterly Earnings on Monday

MorphoSys (NASDAQ:MOR – Get Free Report) will release its earnings data before the market opens on Monday, May 27th. Analysts expect MorphoSys to post earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its quarterly earnings data on Monday, April 29th. The company reported ($2.24) EPS for the […]

United statesMorphosys company profileWells fargo companyGet free reportWells fargoMorphosys daily

MorphoSys (MOR) Set to Announce Quarterly Earnings on Monday

MorphoSys (NASDAQ:MOR – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, May 27th. Analysts expect the company to announce earnings of ($1.30) per share for the quarter. MorphoSys (NASDAQ:MOR – Get Free Report) last posted its earnings results on Monday, April 29th. The company reported ($2.24) earnings […]

United statesWells fargo companyMorphosys company profileGet free reportWells fargoMorphosys daily

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18 38

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18 38
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesMorphosys company profileMorgan stanleyQuadrant capital groupWells fargo companyExchange traded conceptsVirtu financialGet free reportCapital groupTraded conceptsFinancial marketsMorphosys daily

MorphoSys AG (NASDAQ:MOR) Receives $11 78 Consensus Target Price from Brokerages

MorphoSys AG (NASDAQ:MOR) Receives $11 78 Consensus Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsVirtu financialCubist systematic strategiesJpmorgan chase coWells fargo companyPricet rowe associates incMorgan stanleyGoldman sachs group incMorphosys company profileGet free reportSachs groupSystematic strategiesSys stock downGet freeMorphosys daily

Wells Fargo & Company Reaffirms Overweight Rating for MorphoSys (NASDAQ:MOR)

Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […]

United statesLeerink partnrsWells fargo companySigma securitiesQube research technologies ltdJpmorgan chase coMorphosys company profileVirtu financialMorgan stanleyGoldman sachs groupWells fargoFree reportModerate buyGet free reportTechnologies ltdTwo sigma securities